Medical City Dallas Hospital Adopts Perimeter's Innovative OCT Imaging Technology for Surgery
TORONTO and DALLAS, July 2, 2025 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, announced today that Medical City Dallas Hospital, an award-winning 899-bed acute care hospital in the Dallas-Fort Worth area, has adopted the company's current S-Series OCT (optical coherence tomography) technology for high-resolution visualization of tissue microstructures during surgery. The move comes on the heels of the hospital's participation in the pivotal, randomized controlled trial of Perimeter's next-generation B-Series device, which combines proprietary artificial intelligence ("AI") technology with OCT, and is being evaluated by the U.S. Food and Drug Administration for use during breast-conserving surgeries in the United States.
"We are incredibly proud to partner with Medical City Dallas Hospital and its team of surgeons, who are truly innovators in their field," said Perimeter CEO Adrian Mendes. "Working with Dr. DiPasquale and Dr. Anderson and the Medical City Dallas team, who used our B-Series in the randomized controlled pivotal trial, has been invaluable to advancing our next-generation product and we are pleased that they are adopting our commercially approved S-Series to potentially enhance margin visualization in the OR."
Medical City Dallas Hospital is the latest U.S. hospital to adopt the S-Series OCT, as Perimeter continues to deploy the technology nationwide. Cleared by the U.S. Food and Drug Administration (FDA) in 2021 for a general tissue indication, S-Series OCT is a high-resolution technology that, unlike X-ray, magnetic resonance imaging (MRI), or ultrasound, can 'see' disease at the cellular level. It is optimized down to 2mm for identifying regions of interest in tissue microstructures, and features such as blood vessels, ducts, and glands, making it ideal for visualizing surgical margins.
About Perimeter Medical Imaging AI, Inc.
Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V: PINK) (OTCQX: PYNKF) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that was recently evaluated in a pivotal clinical trial, with support from a grant of up to US$7.4 million awarded by the Cancer Prevention and Research Institute of Texas. The company's ticker symbol "PINK" is a reference to the pink ribbons used during Breast Cancer Awareness Month.
S-Series OCT Intended Use and Unapproved Uses
The S-Series OCT is indicated for use as an imaging tool in the evaluation of excised human tissue microstructure by providing two-dimensional, cross-sectional, real-time depth visualization with image review manipulation software for identifying and annotating regions of interest. Perimeter S-Series OCT has 510(k) clearance under a general indication and has not been evaluated by the U.S. FDA specifically for use in breast tissue, breast cancer, other types of cancer, margin evaluation, and reducing re-excision rates. The safety and effectiveness of these uses has not been established. For more information, please visit www.perimetermed.com/disclosures.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains statements that constitute "forward-looking information" within the meaning of applicable Canadian securities legislation. In this news release, words such as "may," "would," "could," "will," "likely," "believe," "expect," "anticipate," "intend," "plan," "estimate," and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking information may relate to management's future outlook and anticipated events or results and may include statements or information regarding the future financial position, business strategy and strategic goals, competitive conditions, research and development activities, projected costs and capital expenditures, research and clinical testing outcomes, taxes and plans and objectives of, or involving, Perimeter. Without limitation, statements regarding the anticipated terms and jurisdictions of the Offering; securities offered thereunder; the timing of the Offering, including the anticipated Closing Date; use of proceeds from the Offering; fees anticipated to be paid to the Agent and terms thereof; regulatory and exchange approvals, including the listing of the common shares offered pursuant to the Offering on the TSXV, are forward-looking information. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, any particular result will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur. Forward-looking information is based on information available at the time and/or management's good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions, and other unpredictable factors, many of which are beyond Perimeter's control. Such forward-looking statements reflect Perimeter's current view with respect to future events, but are inherently subject to significant medical, scientific, business, economic, competitive, political, and social uncertainties and contingencies. In making forward-looking statements, Perimeter may make various material assumptions, including but not limited to (i) the accuracy of Perimeter's financial projections; (ii) obtaining positive results from trials; (iii) obtaining necessary regulatory approvals; and (iv) general business, market, and economic conditions. Further risks, uncertainties and assumptions include, but are not limited to, those applicable to Perimeter and described in Perimeter's Annual Information Form for the year ended December 31, 2024, which is available on Perimeter's SEDAR+ profile at https://www.sedarplus.ca, and could cause actual events or results to differ materially from those projected in any forward-looking statements. Perimeter does not intend, nor does Perimeter undertake any obligation, to update or revise any forward-looking information contained in this news release to reflect subsequent information, events, or circumstances or otherwise, except if required by applicable laws.
Contacts
Stephen Kilmer
Investor Relations
Direct: 647-872-4849
Email: [email protected]
Susan Thomas
Media Relations
Direct: 619-540-9195
Email: [email protected]
Adrian Mendes
Chief Executive Officer
Toll-free: 888-988-7465 (PINK)
Email: [email protected]
SOURCE Perimeter Medical Imaging AI Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
3 hours ago
- Cision Canada
Xojo 2025r2 Focuses on Fundamentals with Core Improvements to Increase Developer Productivity
AUSTIN, Texas, /CNW/ -- Xojo, Inc., the creators of Xojo—a powerful cross-platform development tool and programming language—today announced the release of Xojo 2025 Release 2. This update delivers key performance improvements and new features designed to enhance development across desktop, web and mobile platforms. Among the highlights, compiling with Aggressive Optimization now uses faster, more efficient frameworks. A new shared method has been added, making it easier to generate universally unique identifiers. Platform-specific enhancements include improved XAML integration on Windows and support for direct PDF printing. Web applications benefit from updated WebStyle capabilities, which now support hover, pressed and visited states for more dynamic interfaces. On mobile, updates include multi-photo selection, biometric authentication on Android and easier file sharing. "Xojo remains committed to supporting developers at every level in creating native applications across platforms," said Geoff Perlman, Xojo's Founder and CEO. "This release delivers significant performance improvements and new features that directly address the real-world needs of developers building desktop, web and mobile applications. Our goal is to provide a tool that evolves alongside their challenges and opportunities, helping them become more productive, creative and successful." New Features and Updates: Optimized (faster, larger) frameworks are used when compiling with Aggressive Optimization Updated to SQLite 3.49.2 for all platforms Added shared method Enhanced XAML integration for Windows applications Added support to change the on Windows to use PowerShell in addition to cmd DesktopHTMLViewer now supports printing directly to a PDF file using PrintToPDF Improved WebStyle supports hover, pressed and visited states Added ToPicture method to Web and Mobile MapViewer control to get a map as a picture Select and use multiple photos at once on iOS with MobileImagePicker New Android UserAuthentication class adds facial recognition, fingerprint and passcodes MobileSharingPanel allows sharing of multiple images and files more easily About Xojo Xojo is a cross-platform development tool for building native apps for macOS, Windows, Linux, iOS, Android, the web and Raspberry Pi. For over 25 years, Xojo has supported a growing community of developers passionate about creating powerful applications with ease. Learn more at Download Xojo 2025 Release 2 at
Cision Canada
5 hours ago
- Cision Canada
THESIS GOLD CLOSES C$27.5 MILLION UPSIZED BOUGHT DEAL PRIVATE PLACEMENT
VANCOUVER, BC, /CNW/ - Thesis Gold Inc. ("Thesis" or the "Company") (TSXV: TAU) (WKN: A3EP87) is pleased to announce that it has completed its previously announced underwritten offering, including the full exercise of the over-allotment option, for gross proceeds of approximately C$27.5 million (the "Offering"). The Offering consisted of (i) 5,770,000 common shares of the Company issued as "flow-through shares" with respect to "Canadian exploration expenses" (each within the meaning of the Income Tax Act (Canada)) (the "BC CEE Flow-Through Shares") at a price of C$1.56 per BC CEE Flow-Through Share for aggregate gross proceeds of C$9,001,200; (ii) 11,114,000 common shares of the Company issued as "flow-through shares" with respect to "Canadian exploration expenses" (each within the meaning of the Tax Act) ("National CEE Flow-Through Shares") at a price of C$1.445 per National CEE Flow-Through Share for aggregate gross proceeds of C$16,059,730 and (iii) 1,930,000 common shares of the Company issued as "flow-through shares" with respect to "Canadian exploration expenses" (each within the meaning of the Tax Act) ("Traditional Flow-Through Shares") at a price of C$1.30 per Traditional Flow-Through Share for aggregate gross proceeds of C$2,509,000 (the BC CEE Flow-Through Shares, the National CEE Flow- Through Shares and the Traditional Flow-Through Shares are, collectively referred to as the "Flow-Through Shares"). Existing shareholder Centerra Gold Inc. ("Centerra") participated in the Offering to maintain its shareholder interest in the Company. The gross proceeds of the Offering will be used by the Company to incur eligible "Canadian exploration expenses" that qualify as "flow-through mining expenditures" as such terms are defined in the Income Tax Act (Canada) (the "Qualifying Expenditures") related to the Lawyers Ranch project in British Columbia. Qualifying Expenditures with respect to the BC CEE Flow-Through Shares with also qualify as "BC flow-through mining expenditures" as such term is defined in the Income Tax Act (British Columbia). All Qualifying Expenditures will be renounced in favour of the subscribers for the Flow-Through Shares effective on or before December 31, 2025. Scotiabank acted as sole bookrunner, together with Clarus Securities Inc. as co-lead underwriter, on behalf of a syndicate of underwriters which also included Haywood Securities Inc., Jett Capital Advisors, LLC, National Bank Financial Inc. and Cormark Securities Inc. (collectively, the "Underwriters"). The Underwriters received a cash commission equal to 6.0% of the gross proceeds from the Offering, paid from the Company's existing cash reserves. All securities issued pursuant to the Offering are subject to a four-month hold period expiring on November 9, 2025, in accordance with the policies of the TSX Venture Exchange ("TSXV") and applicable securities laws. The Offering is subject to final approval by the TSXV. The securities issued under the Offering have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the U.S. Securities Act"), or any U.S. state securities laws, and may not be offered, sold or resold in the "United States" (as such term is defined in Regulation S under the U.S. Securities Act) with registration under the U. S. Securities Act and all applicable U.S. state securities laws, or in compliance with an exemption therefrom. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful. About Thesis Gold Inc. Thesis Gold Inc. is a resource development company focused on unlocking the potential of its 100% owned Lawyers-Ranch Project, located in British Columbia's prolific Toodoggone Mining District. The recently completed Preliminary Economic Assessment (PEA) highlights robust project economics, including a 35.2% after-tax IRR and an after-tax NPV5% of C$1.28 billion, demonstrating the potential for significant value creation. The Company's 2025 roadmap includes a robust exploration and drill program, delivery of a Pre-Feasibility Study on the combined Lawyers-Ranch Project, and commencement of the Environmental Impact Assessment Process. Through these strategic moves, Thesis Gold intends to elevate the Lawyers-Ranch Project to the forefront of global precious metals ventures. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release. Cautionary Statement Regarding Forward-Looking Information This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Forward-looking information includes, without limitation, statements regarding the use of proceeds in respect of the Offering, final approval of the TSXV, and the future plans or prospects of the Company. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-looking statements are necessarily based upon a number of assumptions that, while considered reasonable by management, are inherently subject to business, market, and economic risks, uncertainties, and contingencies that may cause actual results, performance, or achievements to be materially different from those expressed or implied by forward-looking statements. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated, or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. Other factors which could materially affect such forward-looking information are described in the risk factors in the Company's most recent annual management's discussion and analysis, which is available on the Company's profile on SEDAR+ at The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.
Winnipeg Free Press
5 hours ago
- Winnipeg Free Press
S&P/TSX composite down more than 100 points, U.S. stock markets also head lower
TORONTO – Canada's main stock index fell more than 100 points, weighed down by losses in the technology sector, while U.S. stock markets also fell. The S&P/TSX composite index was down 129.73 points at 26,890.55. In New York, the Dow Jones industrial average was down 147.92 points at 44,258.44. The S&P 500 index was down 7.61 points at 6,222.37, while the Nasdaq composite was down 7.41 points at 20,405.11. The Canadian dollar traded for 73.10 cents US compared with 73.23 cents US on Monday. The August crude oil contract was up 15 cents US at US$68.08 per barrel. The August gold contract was down US$39.70 at US$3,303.10 an ounce. Monday Mornings The latest local business news and a lookahead to the coming week. This report by The Canadian Press was first published July 8, 2025. Companies in this story: (TSX:GSPTSE, TSX:CADUSD)
